Providence Alaska Medical Center is Alaska's largest hospital by revenue and number of beds. It has 401 beds, 1190 nurses and more than 850 physicians on staff. It is often ranked the largest private employer in Alaska.

There are 401 beds in Providence Alaska Medical Center.

During the past decade, Providence Alaska Medical Center conducted 201 clinical trials. In the 10-year time frame, 201 clinical trials started and 111 clinical trials were completed, i.e. on average, 55.2% percent of trials that started reached the finish line to date. In the past 5 years, 75 clinical trials started and 81 clinical trials were completed. i.e. 108% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Alaska Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 136 trials, followed by "Alliance for Clinical Trials in Oncology" with 37 trials sponsored, "SWOG Cancer Research Network" with 37 trials sponsored, "Children's Oncology Group" with 20 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Alaska Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 150 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "Cystic Fibrosis Foundation" with 5 trials as a collaborator. Other collaborators include 85 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Providence Alaska Medical Center" are "Breast Cancer" (14 trials), "Recurrent Neuroblastoma" (14 trials), "Recurrent Hepatoblastoma" (13 trials), "Recurrent Malignant Solid Neoplasm" (13 trials) and "Refractory Malignant Solid Neoplasm" (13 trials). Many other conditions were trialed in "Providence Alaska Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Alaska Medical Center" are "Drug" (249 trials), "Other" (166 trials), "Biological" (113 trials), "Procedure" (82 trials) and "Radiation" (59 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (95 trials), "Quality-of-Life Assessment" (64 trials), "Computed Tomography" (43 trials), "Biospecimen Collection" (41 trials) and "Questionnaire Administration" (38 trials). Other intervention names were less common.

The vast majority of trials in "Providence Alaska Medical Center" are 252 trials for "All" genders, 52 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Alaska Medical Center". undefined are not yet recruiting, 82 are recruiting, 135 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in Providence Alaska Medical Center, 7 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Alaska Medical Center, 12 "Phase 1" clinical trials were conducted, 138 "Phase 2" clinical trials and 152 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".

Providence Alaska Medical Center has several departments that took part in Clinical trials: "Providence Cancer Center" - 47 trials